Elekta AB EBITDA 2013-2025 | EKTAY
Elekta AB ebitda from 2013 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Elekta AB Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $299 |
| 2023 | $239 |
| 2022 | $302 |
| 2021 | $356 |
| 2020 | $304 |
| 2019 | $292 |
| 2018 | $267 |
| 2017 | $202 |
| 2016 | $197 |
| 2015 | $195 |
| 2014 | $340 |
| 2013 | $359 |
| 2012 | $314 |
| Elekta AB Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-01-31 | $75 |
| 2024-10-31 | $69 |
| 2024-07-31 | $46 |
| 2024-04-30 | $85 |
| 2024-01-31 | $77 |
| 2023-10-31 | $72 |
| 2023-07-31 | $65 |
| 2023-04-30 | $100 |
| 2023-01-31 | $59 |
| 2022-10-31 | $41 |
| 2022-07-31 | $38 |
| 2022-04-30 | $93 |
| 2022-01-31 | $63 |
| 2021-10-31 | $89 |
| 2021-07-31 | $57 |
| 2021-04-30 | $95 |
| 2021-01-31 | $93 |
| 2020-10-31 | $98 |
| 2020-07-31 | $70 |
| 2020-04-30 | $102 |
| 2020-01-31 | $80 |
| 2019-10-31 | $65 |
| 2019-07-31 | $57 |
| 2019-04-30 | $113 |
| 2019-01-31 | $61 |
| 2018-10-31 | $70 |
| 2018-07-31 | $49 |
| 2018-04-30 | $113 |
| 2018-01-31 | $63 |
| 2017-10-31 | $66 |
| 2017-07-31 | $25 |
| 2017-04-30 | $94 |
| 2017-01-31 | $38 |
| 2016-10-31 | $47 |
| 2016-07-31 | $24 |
| 2016-04-30 | $123 |
| 2016-01-31 | $-1 |
| 2015-10-31 | $58 |
| 2015-07-31 | $17 |
| 2015-04-30 | $69 |
| 2015-01-31 | $19 |
| 2014-10-31 | $42 |
| 2014-07-31 | $-19 |
| 2014-04-30 | $157 |
| 2014-01-31 | $52 |
| 2013-10-31 | $64 |
| 2013-07-31 | $29 |
| 2013-04-30 | $228 |
| 2013-01-31 | $57 |
| 2012-10-31 | $65 |
| 2012-07-31 | $6 |
| 2012-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $1.960B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||